Zoetis to Participate in the William Blair 44th Annual Growth Stock Conference

Rhea-AI Summary

Zoetis (NYSE: ZTS) will attend the William Blair 44th Annual Growth Stock Conference on June 4, 2024.

Wetteny Joseph, Executive Vice President and CFO, will represent the company and answer analysts' questions. His presentation is scheduled for 2:40 p.m. CT.

Investors and interested parties can access the live audio webcast of the presentation via the Zoetis investor relations website. A replay will be available following the event.

Positive

• Participation in a high-profile conference like William Blair can enhance Zoetis's visibility and credibility among investors.
• Direct engagement by CFO Wetteny Joseph provides transparency and builds investor confidence.

Negative

• No new product launches, financial updates, or significant business developments were announced.
• The press release lacks detailed financial data and specific growth metrics, which might concern investors looking for concrete information.

PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) will participate in the William Blair 44^th Annual Growth Stock Conference on Tuesday, June 4, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 2:40 p.m. CT.

Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetis.com.

ZTS-COR
ZTS-IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20240521532091/en/

Media Contacts:

Jenielle Alonso

1-973-945-4333 (o)

jenielle.alonso@zoetis.com

Laura Panza

1-973-975-5176 (o)

laura.panza@zoetis.com

Investor Contacts:

Steve Frank

1-973-822-7141 (o)

steve.frank@zoetis.com

Nick Soonthornchai

1-973-443-2792 (o)

nick.soonthornchai@zoetis.com

Source: Zoetis Inc.

FAQ

When will Zoetis participate in the William Blair 44th Annual Growth Stock Conference?

Zoetis will participate on June 4, 2024.

Who will represent Zoetis at the William Blair Growth Stock Conference?

Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent Zoetis.

What time is Zoetis's presentation at the William Blair Conference?

Wetteny Joseph is scheduled to present at 2:40 p.m. CT.

How can investors access the Zoetis presentation at the William Blair Conference?

Investors can access a live audio webcast via the Zoetis investor relations website. A replay will be available after the event.